Abstract:A gene fragment encoding three copies of proinsulin C-peptide was synthesized and expressed in E. coli and the recombinant proinsulin C-peptide was produced through site-specific cleavage of the resulting gene products. The fusion protein was expressed at high level, about 80 mg/L, as a soluble product in the cytoplasm. Ni-NTA affinity chromatography efficiently separated the expressed fusion protein from the supernatant, to obtain about 37.5 mg/L of the fusion protein with 70% purity. Enzymatic digestion by trypsin and carboxypeptidase B of the fusion protein efficiently released native C-peptide, the overall yield of recombinant C-peptide at a purity over 95% was 1.5 mg/L. The good agreement of amino acids composition, together with shown similarities of the recombinant C-peptide to C-peptide standard in the comparative RP-HPLC analysis and IMMULITE C-Peptide quantitative assay, suggested that the recombinant C-peptide obtained in this report was the native human C-peptide. The investigation of the chemical stability of recombinant human C-peptide in aqueous solutions by RP-HPLC was also reported. The degradation of the recombinant C-peptide showed a marked dependence on pH and temperature. The degradation reaction of C-peptide occurred immediately in pH 3 or pH 9 buffered solution. The degradation reaction of C-peptide followed first-order kinetics in pH 3 buffered solution at 37 degrees C or 70 degrees C, only 40.3% of C-peptide was remained after 10 h at 70 degrees C. The maximum stability was achieved at pH 7.4, more than 90% of C-peptide were detected at pH 7.4 and 37 degrees C after 10 h and at pH 7.4 and 70 degrees C after 5 h. 99% and 96% of C-peptide was remained at pH 7.4 and 37 degrees C after 10 h with and without 10 g/L BSA respectively.

Construction of Met-Lys-double-C peptide human proinsulin gene and its expression and characterization

Production of Human Insulin in an E. Coli System with Met-Lys-human Proinsulin As the Expressed Precursor.

Cloning,expression and purification of recombinant human proinsulin C-peptide in E.coli

Human Proinsulin C-Peptide from A Precursor Overexpressed in Pichia Pastoris

Cloning, Expression, and Purification of Recombinant Human-Insulin Analogue Gene in E.coli

CONSTRUCTION AND EXPRESSION OF INTRA-A CHAIN DISULFIDE BOND SHIFT MUTANT IN HUMAN PROINSULIN GENE

Cloning of CTB-PROIN fusion gene and its expression in Escherichia coli]

A Study on the Expression of Site-Directed Mutated Human Proinsulin Gene in Non-Β Cell Lines

Codon Optimization of Human Proinsulin and Expression in Pichia Pastoris

Secretive expression of human proinsulin gene at high level in E. coli

Construction, Preparation and Properties of a Novel Short-Acting Human Insulin Analog

Preparation of Tyr-C-peptide from genetically altered human insulin precursor.

Study on preparation and unique properties of a novel insulin analogue with N-terminal Arg-4, Pro-3, Lys-2, Pro-1extension at insulin B-chain

Synthesis of Human Proinsulin C-peptide and Preparation of Specific Antibody to It.

Expression of C-peptide Multiple Gene Copies in Escherichia Coli and Stabilities of C-peptide in Aqueous Solution.

Construction,expression and Characterization of Recombinant Fusion Protein HSA-PTH(1-34) in Pichia Pastoris

[CDNA Cloning of Human Leptin and Its Expression].

Construction of a Transgenic Pichia Pastoris Strain Yielding Human Insulin

Construction of Wide-Type LPL and Compound Mutation LPL and Preparation of Polyclone Antibody

Mature Insulin Production by Engineered Non-Beta Cells.

Application of Recombinant Carboxypeptidase B in the Preparation of Proinsulin C-peptide